Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 300 | Published : January 2022 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

The respiratory diseases drugs market consists of sales of respiratory diseases drugs and related services by entities (organizations, sole traders and partnerships) that produce drugs to treat respiratory diseases such as asthma, acute bronchitis, emphysema, cystic fibrosis and other diseases. This industry includes establishments that produce anti-asthmatics and COPD drugs to prevent acute attacks caused by respiratory diseases and cough and cold preparations to treat cough and cold. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral®, Coldrex® and Lemsip®.

The main types of respiratory diseases drugs are anti-asthmatics and copd drugs, cough and cold preparations. Any medication that relieves the symptoms of asthma is considered an anti-asthmatic drugs. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global respiratory diseases drugs market size is expected to decline from $142.57 billion in 2021 to $154.79 billion in 2022 at a compound annual growth rate (CAGR) of 8.6%. The change in the respiratory diseases drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The respiratory diseases drugs market is expected to reach $292.01 billion in 2026 at a CAGR of 17.2%.

During the forecast period, the growth of the respiratory diseases drugs market will be restrained by patent expiration of branded respiratory diseases drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value.

Companies in the respiratory drugs market are offering drugs for customized individual treatment for better treatment against respiratory diseases. Personalized medicine, also referred to as precision medicine, aims to provide medical care according to the patient’s individual characteristics and genetic makeup. Precision therapies are increasingly being adopted in the respiratory drugs market as firms increasingly let go of the one-size-fits-all model for common respiratory conditions. Companies such as GSK, Teva Pharmaceuticals and AstraZeneca have already invested in personalized medicine for respiratory issues such as asthma. For example, PTC Therapeutics, is developing a drug, which aims to cater to a respiratory mutation which affects about 10% of the population.

Companies manufacturing respiratory drugs are increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators which are objectively measured and evaluated for biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. It can also help predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in this market are investing in the development of biomarkers for use in various activities such as tracking drug activity, the pharmacodynamics (relationship between the drug concentration at the site of action and the biochemical and physiological effect) of drugs and to study diseases and treatment pathways. Companies such as Genentech and Janssen are increasingly investing in the use of biomarkers for understanding the efficacy of a potential respiratory drug. For example, Janssen has partnership with U-BIOPRED (unbiased biomarkers in prediction of respiratory disease outcomes), a group in Europe that aims to understand more about severe asthma.

Major companies in the respiratory diseases drugs market include Boehringer Ingelheim GmbH, Vertex Pharmaceuticals, AstraZeneca, Pfizer Inc., GlaxosmithKline, Novartis AG, Johnson & Johnson, Reckitt Benckiser Group plc, Mylan N.V., and Sanofi S.A.

North America was the largest region in the respiratory diseases drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the respiratory diseases drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory diseases drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global respiratory diseases drugs market is segmented -

1) By Type: Anti-Asthmatics and COPD Drugs, Cough and Cold Preparations

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    Table Of Contents

    1. Executive Summary

    2. Report Structure

    3. Respiratory Diseases Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Respiratory Diseases Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Respiratory Diseases Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Respiratory Diseases Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Respiratory Diseases Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Respiratory Diseases Drugs

    9. Respiratory Diseases Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Respiratory Diseases Drugs Market Regional Analysis

    10.1. Global Respiratory Diseases Drugs Market, 2021, By Region, Value ($ Billion)

    10.2. Global Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    10.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

    11. Respiratory Diseases Drugs Market Segmentation

    11.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Anti-Asthmatics And COPD Drugs

    Cough And Cold Preparations

    11.2. Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Respiratory Diseases Drugs Market Metrics

    12.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2016-2026, Global

    12.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2016-2026, Global

    13. Asia-Pacific Respiratory Diseases Drugs Market

    13.1. Asia-Pacific Respiratory Diseases Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics

    13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Asia-Pacific Countries

    13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Asia-Pacific Countries

    13.6. Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis

    13.7.1. China Respiratory Diseases Drugs Market

    13.7.1.1. China Respiratory Diseases Drugs Market Overview

    13.7.1.2. China Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.1.3. China Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2. Australia Respiratory Diseases Drugs Market

    13.7.2.1. Australia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2.2. Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.3. Hong Kong Respiratory Diseases Drugs Market

    13.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4. India Respiratory Diseases Drugs Market

    13.7.4.1. India Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4.2. India Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5. Indonesia Respiratory Diseases Drugs Market

    13.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5.2. Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6. Japan Respiratory Diseases Drugs Market

    13.7.6.1. Japan Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6.2. Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.7. Malaysia Respiratory Diseases Drugs Market

    13.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.8. New Zealand Respiratory Diseases Drugs Market

    13.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.9. Philippines Respiratory Diseases Drugs Market

    13.7.9.1. Philippines Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.10. Singapore Respiratory Diseases Drugs Market

    13.7.10.1. Singapore Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11. South Korea Respiratory Diseases Drugs Market

    13.7.11.1. South Korea Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11.2. South Korea Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.12. Thailand Respiratory Diseases Drugs Market

    13.7.12.1. Thailand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.13. Vietnam Respiratory Diseases Drugs Market

    13.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14. Western Europe Respiratory Diseases Drugs Market

    14.1. Western Europe Respiratory Diseases Drugs Market Overview

    14.2. Western Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    14.3. Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    14.4. Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Respiratory Diseases Drugs Market Metrics

    14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Western Europe Countries

    14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Western Europe Countries

    14.6. Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis

    14.7.1. Austria Respiratory Diseases Drugs Market

    14.7.1.1. Austria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.2. Belgium Respiratory Diseases Drugs Market

    14.7.2.1. Belgium Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.3. Denmark Respiratory Diseases Drugs Market

    14.7.3.1. Denmark Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.4. Finland Respiratory Diseases Drugs Market

    14.7.4.1. Finland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5. France Respiratory Diseases Drugs Market

    14.7.5.1. France Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5.2. France Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6. Germany Respiratory Diseases Drugs Market

    14.7.6.1. Germany Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6.2. Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.7. Ireland Respiratory Diseases Drugs Market

    14.7.7.1. Ireland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.8. Italy Respiratory Diseases Drugs Market

    14.7.8.1. Italy Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.9. Netherlands Respiratory Diseases Drugs Market

    14.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.10. Norway Respiratory Diseases Drugs Market

    14.7.10.1. Norway Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.11. Portugal Respiratory Diseases Drugs Market

    14.7.11.1. Portugal Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.12. Spain Respiratory Diseases Drugs Market

    14.7.12.1. Spain Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.13. Sweden Respiratory Diseases Drugs Market

    14.7.13.1. Sweden Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.14. Switzerland Respiratory Diseases Drugs Market

    14.7.14.1. Switzerland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15. UK Respiratory Diseases Drugs Market

    14.7.15.1. UK Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15.2. UK Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15. Eastern Europe Respiratory Diseases Drugs Market

    15.1. Eastern Europe Respiratory Diseases Drugs Market Overview

    15.2. Eastern Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    15.3. Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    15.4. Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics

    15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Eastern Europe Countries

    15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Eastern Europe Countries

    15.6. Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis

    15.7.1. Czech Republic Respiratory Diseases Drugs Market,  

    15.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.2. Poland Respiratory Diseases Drugs Market

    15.7.2.1. Poland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.3. Romania Respiratory Diseases Drugs Market

    15.7.3.1. Romania Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4. Russia Respiratory Diseases Drugs Market

    15.7.4.1. Russia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4.2. Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16. North America Respiratory Diseases Drugs Market

    16.1. North America Respiratory Diseases Drugs Market Overview

    16.2. North America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    16.3. North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    16.4. North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    16.5. North America, Respiratory Diseases Drugs Market Metrics

    16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, North America Countries

    16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, North America Countries

    16.6. North America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7. North America Respiratory Diseases Drugs Market: Country Analysis

    16.7.1. Canada Respiratory Diseases Drugs Market

    16.7.1.1. Canada Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.2. Mexico Respiratory Diseases Drugs Market

    16.7.2.1. Mexico Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3. USA Respiratory Diseases Drugs Market

    16.7.3.1. USA Respiratory Diseases Drugs Market Overview

    16.7.3.2. USA Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3.3. USA Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17. South America Respiratory Diseases Drugs Market

    17.1. South America Respiratory Diseases Drugs Market Overview

    17.2. South America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    17.3. South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    17.4. South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    17.5. South America, Respiratory Diseases Drugs Market Metrics

    17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, South America Countries

    17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, South America Countries

    17.6. South America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7. South America Respiratory Diseases Drugs Market: Country Analysis

    17.7.1. Argentina Respiratory Diseases Drugs Market

    17.7.1.1. Argentina Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2. Brazil Respiratory Diseases Drugs Market

    17.7.1.1. Brazil Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2.2. Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.3. Chile Respiratory Diseases Drugs Market

    17.7.3.1. Chile Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.4. Colombia Respiratory Diseases Drugs Market

    17.7.4.1. Colombia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.5. Peru Respiratory Diseases Drugs Market

    17.7.5.1. Peru Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.6. Venezuela Respiratory Diseases Drugs Market

    17.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18. Middle East Respiratory Diseases Drugs Market

    18.1. Middle East Respiratory Diseases Drugs Market Overview

    18.2. Middle East, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    18.3. Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    18.4. Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Respiratory Diseases Drugs Market Metrics

    18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Middle East Countries

    18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Middle East Countries

    18.6. Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7. Middle East Respiratory Diseases Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Respiratory Diseases Drugs Market

    18.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.2. Israel Respiratory Diseases Drugs Market

    18.7.2.1. Israel Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.3. Turkey Respiratory Diseases Drugs Market

    18.7.3.1. Turkey Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.4. UAE Respiratory Diseases Drugs Market

    18.7.4.1. UAE Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19. Africa Respiratory Diseases Drugs Market

    19.1. Africa Respiratory Diseases Drugs Market Overview

    19.2. Africa, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)

    19.3. Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    19.4. Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    19.5. Africa, Respiratory Diseases Drugs Market Metrics

    19.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Africa Countries

    19.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Africa Countries

    19.6. Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7. Africa Respiratory Diseases Drugs Market: Country Analysis

    19.7.1. Egypt Respiratory Diseases Drugs Market

    19.7.1.1. Egypt Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.2. Nigeria Respiratory Diseases Drugs Market

    19.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.3. South Africa Respiratory Diseases Drugs Market

    19.7.3.1. South Africa Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    20. Respiratory Diseases Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Boehringer Ingelheim GmbH

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. Vertex Pharmaceuticals

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. AstraZeneca

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Pfizer Inc.

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. GlaxosmithKline

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Respiratory Diseases Drugs Market In 2026- Growth Countries

    23.2. Global Respiratory Diseases Drugs Market In 2026- Growth Segments

    23.3. Global Respiratory Diseases Drugs Market In 2026- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Respiratory Diseases Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4: Global Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5: Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 12: Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2016-2026, Global
  • Table 13: Asia-Pacific, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 17: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Asia-Pacific Countries
  • Table 18: Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19: China Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20: China Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21: Australia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22: Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23: Hong Kong Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24: India Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25: India Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26: Indonesia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27: Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28: Japan Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29: Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30: Malaysia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31: New Zealand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32: Philippines Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33: Singapore Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34: South Korea Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35: Thailand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36: Vietnam Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37: Western Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 38: Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 39: Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 41: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Western Europe Countries
  • Table 42: Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43: Austria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44: Belgium Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45: Denmark Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46: Finland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47: France Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48: France Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49: Germany Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50: Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51: Ireland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52: Italy Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53: Netherlands Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54: Norway Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55: Portugal Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56: Spain Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57: Sweden Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58: Switzerland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59: UK Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60: UK Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 61: Eastern Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 65: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Eastern Europe Countries
  • Table 66: Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67: Czech Republic Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68: Poland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69: Romania Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70: Russia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 71: Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 72: North America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 73: North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 74: North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, North America Countries
  • Table 76: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, North America Countries
  • Table 77: North America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78: Canada Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79: Mexico Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 80: USA Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 81: USA Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 82: South America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 83: South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 84: South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, South America Countries
  • Table 86: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, South America Countries
  • Table 87: South America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88: Argentina Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89: Brazil Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90: Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91: Chile Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 92: Colombia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 93: Peru Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 94: Venezuela Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95: Middle East, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 96: Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 97: Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 99: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Middle East Countries
  • Table 100: Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 101: Saudi Arabia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 102: Israel Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 103: Turkey Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104: UAE Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105: Africa, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 106: Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 107: Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Africa Countries
  • Table 109: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Africa Countries
  • Table 110: Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 111: Egypt Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 112: Nigeria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 113: South Africa Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 114: Boehringer Ingelheim GmbH Financial Performance
  • Table 115: Vertex Pharmaceuticals Financial Performance
  • Table 116: AstraZeneca Financial Performance
  • Table 117: Pfizer Inc Financial Performance
  • Table 118: GlaxosmithKline Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Respiratory Diseases Drugs Market In 2026- Growth Countries
  • Table 124: Global Respiratory Diseases Drugs Market In 2026- Growth Segments
  • Table 125: Global Respiratory Diseases Drugs Market In 2026- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Respiratory Diseases Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4: Global Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5: Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 12: Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2016-2026, Global
  • Figure 13: Asia-Pacific, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 17: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Asia-Pacific Countries
  • Figure 18: Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19: China Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20: China Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21: Australia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22: Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23: Hong Kong Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24: India Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25: India Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26: Indonesia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27: Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28: Japan Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29: Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30: Malaysia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31: New Zealand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32: Philippines Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33: Singapore Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34: South Korea Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35: Thailand Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36: Vietnam Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37: Western Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 38: Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 39: Western Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 40: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 41: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Western Europe Countries
  • Figure 42: Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43: Austria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44: Belgium Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45: Denmark Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46: Finland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47: France Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48: France Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49: Germany Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50: Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51: Ireland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52: Italy Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53: Netherlands Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54: Norway Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55: Portugal Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56: Spain Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57: Sweden Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58: Switzerland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59: UK Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60: UK Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 61: Eastern Europe, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 62: Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 63: Eastern Europe, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 64: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 65: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Eastern Europe Countries
  • Figure 66: Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67: Czech Republic Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68: Poland Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69: Romania Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70: Russia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 71: Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 72: North America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 73: North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 74: North America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 75: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, North America Countries
  • Figure 76: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, North America Countries
  • Figure 77: North America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78: Canada Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79: Mexico Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 80: USA Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 81: USA Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 82: South America, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 83: South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 84: South America, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 85: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, South America Countries
  • Figure 86: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, South America Countries
  • Figure 87: South America Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88: Argentina Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89: Brazil Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90: Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91: Chile Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 92: Colombia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 93: Peru Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 94: Venezuela Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95: Middle East, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 96: Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 97: Middle East, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 98: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 99: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Middle East Countries
  • Figure 100: Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 101: Saudi Arabia Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 102: Israel Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 103: Turkey Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104: UAE Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105: Africa, Respiratory Diseases Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 106: Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 107: Africa, Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 108: Per Capita Average Respiratory Diseases Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 109: Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2021, Africa Countries
  • Figure 110: Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 111: Egypt Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 112: Nigeria Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 113: South Africa Respiratory Diseases Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 114: Boehringer Ingelheim GmbH Financial Performance
  • Figure 115: Vertex Pharmaceuticals Financial Performance
  • Figure 116: AstraZeneca Financial Performance
  • Figure 117: Pfizer Inc Financial Performance
  • Figure 118: GlaxosmithKline Financial Performance
  • Figure 119: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 120: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 121: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 123: Global Respiratory Diseases Drugs Market In 2026- Growth Countries
  • Figure 124: Global Respiratory Diseases Drugs Market In 2026- Growth Segments
  • Figure 125: Global Respiratory Diseases Drugs Market In 2026- Growth Strategies
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Masks (N95 Respirators And Other Surgical Masks) Market 2022 – By Type (N95 Respirator, Common Grade Surgical Masks, Others (Comfort Masks/Dust Masks)), By End User (Hospitals and Clinics, Individual, Other End Users), By Nature (Reusable, Disposable), And By Region, Opportunities And Strategies – Global Forecast To 2031 
View Report
Respiratory Monitoring Devices Global Market Report 2024 – By Type (Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types), By Application (Chronic Obstructive Pulmonary Disease (COPD), Infectious Diseases, Asthma, Other Applications), By End-User (Laboratories, Hospitals, Home Use) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anesthesia And Respiratory Devices Global Market Report 2024 – By Type (Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By Gender (Male, Female), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024 – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests), By Disease Type (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases), By End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Technology (HEPA Filter, Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, Other Technologies), By End-User (Homecare settings, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Disposables Global Market Report 2024 – By Type (Masks, Tubes, Inhalers, Other Types), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases), By Application (Adult, Pediatric & Neonatal), By End User (Hospitals, Clinics, Ambulatory Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By Therapy (Preventive, Curative), By Route Of Administration (Oral, Inhaled, Intravenous, Subcutaneous), By Age Group (Below 5, 5-14, 15-60, Above 60), By Prescription (Prescription, Over The Counter (OTC)), By Drug Type (Branded, Generic) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Frequently Asked Questions

What is the definition of the respiratory diseases drugs market?

The respiratory diseases drugs market consists of sales of respiratory diseases drugs and related services by entities that produce drugs to treat respiratory diseases such as asthma, acute bronchitis, emphysema, cystic fibrosis and other diseases. request a sample here

How will the respiratory diseases drugs market drivers and restraints affect respiratory diseases drugs market dynamics? What forces will shape the respiratory diseases drugs industry going forward?

The respiratory diseases drugs market growth is aided by companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. However, some respiratory diseases drugs market restraints include patent expiration of branded central nervous system drugs. request a sample here

What is the forecast market size of the respiratory diseases drugs market?

The respiratory diseases drugs market forecast is expected to reach $98.81 billion in 2025 at a compound annual growth rate of 5%. request a sample here

How is the respiratory diseases drugs market segmented?

The global respiratory diseases drugs market is segmented -
1) By Type: Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
request a sample here

Which region has largest share, and what is the market size and growth by geography according to the respiratory diseases drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global respiratory diseases drugs market?

Top competitors in the respiratory diseases drugs market are GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson. request a sample here.

What are the key trends in the global respiratory diseases drugs market?

Major trends influencing the respiratory diseases drugs market include use of biomarkers in the drug development process to reduce the time taken to bring the product into the market. request a sample here.

What are the major opportunities in the respiratory diseases drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global respiratory diseases drugs market, request a sample here.

How does the respiratory diseases drugs market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.